Chief, Division of Pediatric Surgery
Principal Investigator, Saban Research Institute
Attending Physician
Professor of Surgery with Tenure, Keck School of Medicine of USC
  • Summary
  • Publications
  • Research
  • Media
  • Locations

Tracy Grikscheit, MD is an attending surgeon and associate professor of surgery at Children’s Hospital Los Angeles. Her past research and current interests are centered on engineering solutions for a congenital and acquired intestinal deficit which has been reported in numerous peer-review journals and national and international presentations. Dr. Grikscheit is a funded primary investigator conducting research at The Saban Research Institute.

Clinical Interests

Surgery of Infancy and Childhood; Neonatal Surgery; Solid Tumors in Children; Congenital Anomalies


Medical School: 

Columbia University College of Physicians & Surgeons


Massachusetts General Hospital: General Surgery


Massachusetts General Hospital: General Surgery


Seattle Children's Hospital and Regional Medical Center: Pediatric Surgery; Research Fellow Department of Surgery Massachusetts General Hospital for Children



Surgery, American Board of Surgery
Pediatric Surgery, American Board of Surgery

Professional Memberships: 

American College of Surgeons (ACS)
American Academy of Pediatrics (AAP)
Society of University Surgeons (SUS)
American Pediatric Surgical Association (APSA)
Association for Academic Surgery (AAS)

Research Interests: 

Tracy Grikscheit, MD, is a practicing pediatric surgeon and scientist with a laboratory focused on regenerative medicine and tissue engineering at The Saban Research Institute of Children's Hospital Los Angeles. In the hospital, she cares for children who are born prematurely, and therefore are at increased risk for multiple medical conditions that may lead to intestinal lack or loss. One of these conditions is necrotizing enterocolitis (NEC), a potentially life-threatening intestinal problem. For the most severe cases of NEC, the only solution is surgical removal of the small intestine. However, this option leaves the baby dependent on intravenous feeding and the child is also at risk for liver damage from subsequent intravenous nutrition. Another option is small bowel transplantation, but graft and patient survival rates are still too low. Dr. Grikscheit envisions a better solution. The small intestine is an exquisitely regenerative organ. It is an elegant model to better understand organ-specific stem cells and the regenerative cells can be harnessed to make new gastrointestinal tissue for eventual clinical applications. Understanding how to generate tissue-engineered intestines, whether esophagus, stomach, small intestine, or colon, may also inform us how to expand the list of organs that can be tissue-engineered.

Visit the Grikscheit Laboratory.



Children's Hospital Los Angeles

4650 Sunset Blvd.
Pediatric Surgery, MS 100
Los Angeles, CA 90027
Phone: 323-361-5901Office
Fax: 323-361-3534Fax